Boehringer Ingelheim (Canada) Ltd

Boehringer Ingelheim is a research-driven pharmaceutical group of companies committed to the development of innovative, cost-effective medicines and finding medical breakthroughs for therapies which fulfill unmet medical needs. It is the largest privately-owned research-based pharmaceutical company and ranks among the top 20 pharmaceutical companies in the world. For more than 125 years Boehringer Ingelheim has been committed to the research and development of innovative medicines that help improve the lives of patients and their families. Our drug discovery focuses on six major therapeutic areas: respiratory diseases, cardiometabolic diseases, oncology, neurological diseases, immunology and inflammation, and infectious diseases. Boehringer Ingelheim Canada operations have been based in Burlington, Ontario since 1978 and the company has more than 550 employees across Canada. For more information please visit our website: www.boehringer-ingelheim.ca